vs
Side-by-side financial comparison of CHAIN BRIDGE BANCORP INC (CBNA) and Monte Rosa Therapeutics, Inc. (GLUE). Click either name above to swap in a different company.
CHAIN BRIDGE BANCORP INC is the larger business by last-quarter revenue ($14.7M vs $12.8M, roughly 1.2× Monte Rosa Therapeutics, Inc.). CHAIN BRIDGE BANCORP INC runs the higher net margin — 36.4% vs -212.1%, a 248.5% gap on every dollar of revenue. Monte Rosa Therapeutics, Inc. produced more free cash flow last quarter ($99.8M vs $11.5M).
CHAIN BRIDGE BANCORP INCCBNAEarnings & Financial Report
Suburban Bancorp, Inc. was a publicly traded multibank holding company headquartered in suburban Chicago. It was founded by Gerald F. Fitzgerald, father of former U.S. Senator Peter Fitzgerald, and majority owned by the Fitzgerald family. Bank of Montreal acquired Suburban Bancorp, Inc. by merger in 1994. Harris Bankmont, Inc., an American subsidiary of Bank of Montreal, merged with Suburban Bankcorp to expand the Harris Bank presence in the Chicago area. The all-stock deal was valued at $246...
Monte Rosa Therapeutics is a clinical-stage biotechnology company specializing in the discovery and development of targeted molecular glue degrader therapies. Its pipeline addresses unmet medical needs across oncology, rare genetic disorders and immunological diseases, with operations focused on advancing novel treatments for global patient populations.
CBNA vs GLUE — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $14.7M | $12.8M |
| Net Profit | $5.3M | $-27.1M |
| Gross Margin | — | — |
| Operating Margin | 45.6% | -258.3% |
| Net Margin | 36.4% | -212.1% |
| Revenue YoY | — | 38.5% |
| Net Profit YoY | — | -13.5% |
| EPS (diluted) | $0.81 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $14.7M | — | ||
| Q3 25 | $13.1M | $12.8M | ||
| Q2 25 | $12.6M | $23.2M | ||
| Q1 25 | $14.5M | $84.9M | ||
| Q4 24 | — | $60.6M | ||
| Q3 24 | $16.7M | — | ||
| Q4 23 | — | $0 | ||
| Q3 23 | — | $0 |
| Q4 25 | $5.3M | — | ||
| Q3 25 | $4.7M | $-27.1M | ||
| Q2 25 | $4.6M | $-12.3M | ||
| Q1 25 | $5.6M | $46.9M | ||
| Q4 24 | — | $13.4M | ||
| Q3 24 | $7.5M | — | ||
| Q4 23 | — | $-33.3M | ||
| Q3 23 | — | $-34.9M |
| Q4 25 | 45.6% | — | ||
| Q3 25 | 44.9% | -258.3% | ||
| Q2 25 | 45.8% | -67.1% | ||
| Q1 25 | 48.4% | 51.9% | ||
| Q4 24 | — | 21.4% | ||
| Q3 24 | 56.3% | — | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — |
| Q4 25 | 36.4% | — | ||
| Q3 25 | 35.8% | -212.1% | ||
| Q2 25 | 36.3% | -53.0% | ||
| Q1 25 | 38.6% | 55.2% | ||
| Q4 24 | — | 22.2% | ||
| Q3 24 | 44.8% | — | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — |
| Q4 25 | $0.81 | — | ||
| Q3 25 | $0.72 | — | ||
| Q2 25 | $0.70 | — | ||
| Q1 25 | $0.85 | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $1.64 | — | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $586.6M | $208.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $169.2M | $245.8M |
| Total Assets | $1.8B | $459.8M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $586.6M | — | ||
| Q3 25 | $395.7M | $208.3M | ||
| Q2 25 | $377.3M | $69.4M | ||
| Q1 25 | $629.2M | $78.5M | ||
| Q4 24 | — | $224.3M | ||
| Q3 24 | $639.8M | — | ||
| Q4 23 | — | $128.1M | ||
| Q3 23 | — | $59.1M |
| Q4 25 | $169.2M | — | ||
| Q3 25 | $163.1M | $245.8M | ||
| Q2 25 | $156.9M | $268.1M | ||
| Q1 25 | $151.5M | $275.2M | ||
| Q4 24 | — | $222.9M | ||
| Q3 24 | $104.8M | — | ||
| Q4 23 | — | $179.3M | ||
| Q3 23 | — | $184.5M |
| Q4 25 | $1.8B | — | ||
| Q3 25 | $1.5B | $459.8M | ||
| Q2 25 | $1.4B | $359.6M | ||
| Q1 25 | $1.7B | $393.2M | ||
| Q4 24 | — | $438.7M | ||
| Q3 24 | $1.6B | — | ||
| Q4 23 | — | $303.8M | ||
| Q3 23 | — | $252.1M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $15.6M | $100.4M |
| Free Cash FlowOCF − Capex | $11.5M | $99.8M |
| FCF MarginFCF / Revenue | 78.1% | 781.5% |
| Capex IntensityCapex / Revenue | 28.0% | 5.1% |
| Cash ConversionOCF / Net Profit | 2.92× | — |
| TTM Free Cash FlowTrailing 4 quarters | $17.9M | $145.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $15.6M | — | ||
| Q3 25 | $2.8M | $100.4M | ||
| Q2 25 | $3.4M | $-34.7M | ||
| Q1 25 | $3.1M | $-45.5M | ||
| Q4 24 | — | $128.9M | ||
| Q3 24 | — | — | ||
| Q4 23 | — | $29.6M | ||
| Q3 23 | — | $-24.7M |
| Q4 25 | $11.5M | — | ||
| Q3 25 | $2.5M | $99.8M | ||
| Q2 25 | $2.5M | $-36.4M | ||
| Q1 25 | $1.4M | $-47.1M | ||
| Q4 24 | — | $128.7M | ||
| Q3 24 | — | — | ||
| Q4 23 | — | $27.9M | ||
| Q3 23 | — | $-26.4M |
| Q4 25 | 78.1% | — | ||
| Q3 25 | 18.7% | 781.5% | ||
| Q2 25 | 20.0% | -157.0% | ||
| Q1 25 | 9.8% | -55.4% | ||
| Q4 24 | — | 212.3% | ||
| Q3 24 | — | — | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — |
| Q4 25 | 28.0% | — | ||
| Q3 25 | 2.5% | 5.1% | ||
| Q2 25 | 6.5% | 7.3% | ||
| Q1 25 | 11.6% | 1.9% | ||
| Q4 24 | — | 0.3% | ||
| Q3 24 | — | — | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — |
| Q4 25 | 2.92× | — | ||
| Q3 25 | 0.59× | — | ||
| Q2 25 | 0.73× | — | ||
| Q1 25 | 0.55× | -0.97× | ||
| Q4 24 | — | 9.59× | ||
| Q3 24 | — | — | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
